Ownership history in Integrated Advisors Network LLC Β· 11 quarters on record
This page tracks every 13F SEC filing in which Integrated Advisors Network LLC reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Integrated Advisors Network LLC underperformed the S&P 500 by β42.8% annually on this BMRN position. Timing score: 33% (3/9 decisions correct). Average cost basis: $81.01. Maximum drawdown during holding period: β44.3%.
β Significantly underperformed the S&P 500 by 42.8% ann.
10 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
3 of 9 add/trim decisions correct
Best entry: $54.97 (2025 Q2) Β· Worst: $97.24 (2023 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
6 adds Β· 4 trims. Bought during 2 of 7 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.01% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size